Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis

被引:119
作者
Shao, R [1 ]
Guo, X
机构
[1] Univ Massachusetts, Baystate Med Ctr, Inst Biomed Res, Springfield, MA 01107 USA
[2] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
关键词
human microvascular endothelial cells HMCE-l; line; angiogenesis; growth factor; tyrosine kinase receptor; immortalization;
D O I
10.1016/j.bbrc.2004.07.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Human microvascular endothelial cell-1 (HMEC-1) generated by transfection with SV40 large T antigen has been the prevailing model for in vitro studies on endothelium. However, the transduction of SV40 may lead to unwanted cell behaviors which are absent in primary cells. Thus, establishing a new microvascular endothelial cell line, which is capable of maintaining inherent features of primary endothelial cells, appears to be extremely important. Here, we immortalized primary human microvascular endothelial cells (pHMECs) by engineering the human telomerase catalytic protein (hTERT) into the cells. Endothelial cell-specific markers were examined and the angiogenic responses were characterized in these cells (termed as HMVECs, for human microvascular endothelial cells). We found that VEGF receptor 2 (Flk-1/KDR), tie 1, and tie2 expression is preserved in HMVEC, whereas Flk-1/KDR is absent in HMEC-1. In addition, HMVEC showed similar angiogenic responses to VEGF as HMEC-1. Furthermore, the HMVEC line was found to generate a prominent angiogenic response to periostin, a potent angiogenic factor identified recently. The data indicate that HMVEC may serve as a suitable in vitro endothelium model. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:788 / 794
页数:7
相关论文
共 34 条
[1]
HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[2]
FIBRIN-II INDUCES ENDOTHELIAL-CELL CAPILLARY-TUBE FORMATION [J].
CHALUPOWICZ, DG ;
CHOWDHURY, ZA ;
BACH, TL ;
BARSIGIAN, C ;
MARTINEZ, J .
JOURNAL OF CELL BIOLOGY, 1995, 130 (01) :207-215
[3]
Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[4]
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells [J].
Elenbaas, B ;
Spirio, L ;
Koerner, F ;
Fleming, MD ;
Zimonjic, DB ;
Donaher, JL ;
Popescu, NC ;
Hahn, WC ;
Weinberg, RA .
GENES & DEVELOPMENT, 2001, 15 (01) :50-65
[5]
The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[6]
LONG-TERM CULTURE OF CAPILLARY ENDOTHELIAL-CELLS [J].
FOLKMAN, J ;
HAUDENSCHILD, CC ;
ZETTER, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (10) :5217-5221
[7]
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[8]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[9]
FUNCTIONAL-HETEROGENEITY OF VASCULAR ENDOTHELIAL-CELLS - COMMENTARY [J].
GERRITSEN, ME .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (17) :2701-2711
[10]
Inhibition of telomerase limits the growth of human cancer cells [J].
Hahn, WC ;
Stewart, SA ;
Brooks, MW ;
York, SG ;
Eaton, E ;
Kurachi, A ;
Beijersbergen, RL ;
Knoll, JHM ;
Meyerson, M ;
Weinberg, RA .
NATURE MEDICINE, 1999, 5 (10) :1164-1170